Eosinophils and C4 predict clinical failure of combination immunotherapy with very low dose subcutaneous interleukin-2 and interferon in renal cell carcinoma patients.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples